Internal Medicine, Pulmonary Disease · Flushing, NY
NPI
1821097932
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
136-20 38th Avenue, Ste. Cf-B
Flushing, NY, 11354
Phone (718) 358-8889
Groups this clinician bills Medicare through
Medicare paid, 2024
$86K
1,267 services
Medicare patients, 2024
343
Average age 75
Drug cost, 2024
$8.3M
18,031 prescriptions
Company payments, 2025
$4,179
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kenneth K Sha was code 99213 (office e&m - established), 534 times for 281 patients. In total Kenneth K Sha billed 1,267 services in 25 codes, and Medicare paid $86K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-08-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 534 | 281 | $76.46 | $41K |
| 94060 Pulmonary Function Testing | Office | 220 | 188 | $33.72 | $7,419 |
| 94727 Pulmonary Function Testing | Office | 117 | 105 | $39.41 | $4,611 |
| 94729 Pulmonary Function Testing | Office | 117 | 105 | $51.69 | $6,048 |
| 99203 Office E&M - New | Office | 53 | 53 | $94.18 | $4,992 |
| 99214 Office E&M - Established | Office | 34 | 31 | $110.82 | $3,768 |
| 99442 Telephone Services | Office | 27 | 21 | $74.10 | $2,001 |
| 99204 Office E&M - New | Office | 27 | 27 | $137.90 | $3,723 |
| 36410 Vascular | Office | 25 | 16 | $15.38 | $384 |
| 90471 Vaccine Administration | Office | 24 | 24 | $18.06 | $433 |
| 99406 Behavioral Health Services | Office | 21 | 20 | $16.26 | $341 |
| 95810 Sleep Study | Office | 12 | 12 | $575.43 | $6,905 |
| 90661 Vaccine Product | Office | 12 | 12 | $36.11 | $433 |
By year: 2022 $120K for 1,711 services; 2023 $103K for 1,474 services; 2024 $86K for 1,267 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kenneth K Sha prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 2,796 prescriptions and refills. In total Kenneth K Sha wrote 18,031 Medicare prescriptions that cost $8.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 2,796 | 2,961 | 744 | $72K |
| Famotidine Generic | 2,457 | 2,816 | 582 | $20K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,614 | 1,727 | 245 | $1.1M |
| Montelukast Sodium Generic | 1,360 | 1,724 | 234 | $6,603 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 1,274 | 1,338 | 232 | $605K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 965 | 1,055 | 167 | $660K |
| Theophylline Er Theophylline Anhydrous | 766 | 869 | 110 | $44K |
| Breo Ellipta Fluticasone/Vilanterol | 621 | 735 | 119 | $289K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 546 | 610 | 94 | $290K |
| Symbicort Budesonide/Formoterol Fumarate | 364 | 400 | 82 | $92K |
| Incruse Ellipta Umeclidinium Bromide | 331 | 401 | 67 | $135K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 314 | 314 | 290 | $2,973 |
| Roflumilast Generic | 281 | 335 | 40 | $31K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 270 | 294 | 61 | $33K |
| Spiriva Respimat Tiotropium Bromide | 259 | 288 | 44 | $150K |
Brand drugs: 8,572 claims; generic drugs: 9,438 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kenneth K Sha $4,179 ($4,179 in general payments such as food, travel and fees) from 20 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $725.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 32 | $725 |
| Mallinckrodt Hospital Products Inc. | 17 | $680 |
| GlaxoSmithKline, LLC. GSK | 27 | $590 |
| Regeneron Healthcare Solutions, Inc. REGN | 13 | $381 |
| Actelion Pharmaceuticals US, Inc. JNJ | 11 | $313 |
| Verona Pharma, Inc. VRNA | 11 | $312 |
| Insmed, Inc. INSM | 10 | $227 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $196 |
| Philips North America LLC PHG | 6 | $135 |
| Genzyme Corporation SNY | 3 | $100 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.